National Research Corporation

NRC Healthcare Health Information Services

National Research Corporation’s revenue for fiscal 2025 (year ended December 2025) was $137.4 million, down 3.96% from fiscal 2024. In the quarter to June 2026, revenue grew 3.98%, EPS fell 3,091.5%, free cash flow grew 101.5% and total debt rose 11.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years; insiders bought in the last twelve months.

20.15 0.96 −4.55%
Market cap
$466.9M
P/E
80.6×
Fwd P/E
4.9×
Dividend yield
3.18%
F-score
6/9
Altman Z
3.33
Beneish M
−3.10
Dividend safety
45/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
86.28 42.95 37.15 18.12

+8 more quarters

P/S ratio
3.39 2.67 3.06 2.03
P/FCF ratio
21.94 21.24 26.69 24.34
P/Operating CF
342.52 51.55 58.52 20.55
P/B ratio
72.49 27.43 30.03 19.76
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
3.98 3.19 3.57 2.56
EV/EBITDA
23.74 15.81 16.20 10.31
EV/Operating CF
18.89 16.37 18.56 13.90
EV/FCF
25.76 25.34 31.19 30.69
Quick Ratio
0.48 0.36 0.43 0.39
Current Ratio
0.65 0.52 0.55 0.53
Net Debt/EBITDA
(75.86) 9.20 10.36 7.41
Debt/Assets
63.17% 55.01% 55.62% 56.02%
Debt/Equity
13.13 5.48 5.36 5.31
Asset Turnover
1.01 1.03 1.03 1.04
Operating CF/Net income
(0.42) 2.23 4.82 3.34
Capex/Depreciation
(0.62) (0.84) (0.52) (1.61)
Interest Coverage
(2.45) 4.44 3.41 5.30
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
64.83% 38.56% 41.04% 35.46%
Intangible Assets out of Total Assets
0.50 0.51 0.51 0.50
Share Based Compensation of Revenue
20.83% 4.62% 5.42% 2.67%
Graham Net Nets
(0.22) (0.27) (0.24) (0.36)
Graham Number
1.29 2.35 2.67 3.20
Earnings Yield
1.16% 2.33% 2.69% 5.52%
Free Cash Flow Yield
4.56% 4.71% 3.75% 4.11%
Revenue per Share
1.61 1.60 1.57 1.56
Operating CF per Share
0.06 0.33 0.32 0.62
Capex per Share
(0.06) (0.08) (0.05) (0.16)
Free Cash Flow per Share
0.00 0.25 0.27 0.46
Cash per Share
0.15 0.12 0.18 0.10
Shareholders Equity per Share
0.30 0.62 0.63 0.65
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
0.30 0.62 0.63 0.65
Free Cash Flow
0.06 5.35 6.06 10.18
Working Capital
(12.21) (18.49) (16.41) (18.16)
Capital Expenditures
(1.32) (1.83) (1.12) (3.59)
Net Current Asset Value
(106.80) (101.08) (100.68) (101.00)
EV/EBIT
37.82 22.57 21.74 12.96
Capex to Sales
0.04 0.05 0.03 0.10
Price to Operating Income
32.21 18.92 18.60 10.28
Other line items
Average Receivables
13.25 11.39 11.42 12.23
Average Payables
1.25 2.13 1.18 1.84
Average Assets
138.77 134.87 133.71 133.76
Average Common Equity
13.94 21.58 22.64 24.47

Fold the line items

Columns are period end dates